Form 4: Schrodinger Director Arun Oberoi Receives Significant Equity Compensation

Schrodinger, Inc. Director Arun Oberoi was granted 5,997 Restricted Stock Units and options to purchase 9,341 shares of common stock, aligning his interests with the company's long-term performance.

Summary

• Arun Oberoi, a Director of Schrodinger, Inc. (SDGR), acquired 5,997 shares of common stock through a grant of Restricted Stock Units (RSUs).
• These RSUs were granted on June 18, 2025, at a price of $0 per share, and each RSU represents a contingent right to receive one share of common stock.
• The RSUs are scheduled to vest on the twelve-month anniversary of the grant date (June 18, 2026) or, if earlier, the date of the next annual meeting of stockholders, subject to continued service.
• Following this transaction, Arun Oberoi beneficially owns a total of 17,247 shares of common stock, which includes the 5,997 unvested RSUs.
• Additionally, Mr. Oberoi was granted stock options to purchase 9,341 shares of common stock with an exercise price of $21.05 per share.
• These stock options were also granted on June 18, 2025, and will vest on the twelve-month anniversary of the grant date or the next annual meeting, subject to continued service, and are set to expire on June 18, 2035.

Sentiment

Score: 7

Explanation: The document reports a routine equity compensation grant to a director, which is a positive for aligning interests and retaining talent, but does not provide broader financial or operational news to significantly impact overall sentiment.

Positives

• The grant of RSUs and stock options aligns the interests of Director Arun Oberoi with those of Schrodinger's shareholders, incentivizing long-term performance and value creation.
• The equity grants are part of the Issuer's 2022 Equity Incentive Plan, indicating a structured and established approach to executive and director compensation.

Future Outlook

The grants of RSUs and stock options are subject to continued service, indicating an expectation of Arun Oberoi's ongoing contribution as a director for at least the next twelve months or until the next annual meeting.

Industry Context

This Form 4 filing reflects a standard practice in the biotechnology and software industries, where equity compensation, including RSUs and stock options, is commonly used to attract, retain, and incentivize directors and key personnel, aligning their long-term interests with company performance.

Corporate Governance

Stakeholder Impact

• **Shareholders:** The equity grants align the interests of Director Arun Oberoi with shareholders, potentially fostering long-term value creation.
• **Employees:** While specific to a director, such grants are part of a broader equity incentive plan that may also benefit other key employees, contributing to talent retention.

Next Steps

• Vesting of the 5,997 RSUs and 9,341 stock options on the twelve-month anniversary of the grant date (June 18, 2026) or the date of the next annual meeting of stockholders, subject to continued service.
• Potential exercise of stock options by Arun Oberoi at or after the vesting date and before the expiration date of June 18, 2035.

Key Dates

Keywords

Schrodinger, SDGR, Form 4, insider transaction, stock grant, RSU, Restricted Stock Units, stock option, director compensation, beneficial ownership, equity incentive plan